Klabax Ec (Clarithromycin)

Clarithromycin is a macrolide antibiotic used to treat bacterial infections affecting various organ systems.

• Community‑acquired pneumonia: eradicates the causative bacteria and improves respiratory function.
• Acute bacterial sinusitis: reduces sinus inflammation and clears infection.
• Acute exacerbations of chronic bronchitis: shortens symptom duration and prevents complications.
• Skin and soft‑tissue infections: eliminates pathogenic bacteria and promotes healing.
• Helicobacter pylori eradication (in combination therapy): contributes to ulcer healing and reduces recurrence.

• Clarithromycin inhibits bacterial protein synthesis by binding to the 50S subunit of the ribosome. This binding blocks the translocation step of peptide elongation, preventing the formation of essential proteins required for bacterial growth and replication, leading to a bacteriostatic effect that can become bactericidal at higher concentrations.

Clarithromycin may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate upset stomach.
• Diarrhea: frequent loose stools.
• Abdominal pain: cramping or discomfort.
• Taste disturbance: altered or metallic taste.
• Headache: mild to moderate pain.
• Vomiting: occasional episodes.

Serious or Rare Side Effects

• Severe allergic reactions: rash, swelling, anaphylaxis.
• QT interval prolongation: risk of cardiac arrhythmias.
• Hepatic dysfunction: elevated liver enzymes or hepatitis.
• Clostridioides difficile colitis: severe diarrhea.
• Stevens‑Johnson syndrome: serious skin reaction.

Before initiating clarithromycin therapy, consider the following precautions.

• Liver function assessment: monitor hepatic enzymes in patients with liver disease.
• Cardiac monitoring: avoid in patients with known QT prolongation or taking other QT‑prolonging drugs.
• Renal impairment: dose adjustment may be required for severe kidney dysfunction.
• Allergy screening: do not use in individuals with known macrolide hypersensitivity.
• Drug interaction review: evaluate concomitant medications that may interact.
• Store at room temperature: keep in the original packaging, protect from moisture and heat.

Clarithromycin interacts with several medications; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid)

• Cisapride and pimozide: risk of serious cardiac arrhythmias.
• Simvastatin and other CYP3A4 substrates: increased risk of myopathy.
• Ergot alkaloids: potential for ergotism.
• Colchicine: heightened toxicity, especially in renal impairment.
• Warfarin: enhanced anticoagulant effect, increased INR.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: possible reduction in efficacy.
• Carbamazepine and phenytoin: decreased clarithromycin levels.
• Digoxin: modest increase in serum concentration.
• Theophylline: potential for elevated theophylline levels.
• Antacids containing aluminum or magnesium: may reduce absorption.